ID | Name | Number of studies | |
|---|---|---|---|
| CL_0000624 | CD4-positive, alpha-beta T cell | 48 | |
| CL_0001044 | effector CD4-positive, alpha-beta T cell | 7 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| GPR171 | 4 | 22% ± 6% | 0 | 14 | |
| GZMM | 5 | 35% ± 8% | 0 | 27 | |
| FLT3LG | 4 | 33% ± 13% | 0 | 17 | |
| TRAT1 | 4 | 32% ± 6% | 0 | 20 | |
| TMEM256-PLSCR3 | 3 | 29% ± 11% | 0 | 10 | |
| CD40LG | 3 | 30% ± 7% | 0 | 10 | |
| SH2D2A | 4 | 35% ± 9% | 0 | 20 | |
| CD5 | 4 | 39% ± 7% | 0 | 20 | |
| TIGIT | 3 | 21% ± 5% | 0 | 13 | |
| SIRPG | 3 | 28% ± 3% | 0 | 15 | |
| THEMIS | 3 | 19% ± 4% | 0 | 17 | |
| ZAP70 | 4 | 47% ± 6% | 0 | 27 | |
| GZMK | 3 | 28% ± 6% | 0 | 17 | |
| PRF1 | 3 | 33% ± 22% | 0 | 21 | |
| KLRB1 | 6 | 29% ± 7% | 1 | 26 | |
| GZMA | 5 | 47% ± 18% | 1 | 26 | |
| CISH | 3 | 50% ± 26% | 1 | 9 | |
| CD3G | 5 | 69% ± 10% | 1 | 29 | |
| SLAMF1 | 3 | 27% ± 8% | 1 | 10 | |
| CD28 | 3 | 32% ± 8% | 1 | 12 | |
| SAMD3 | 4 | 21% ± 1% | 1 | 22 | |
| GBP5 | 4 | 44% ± 8% | 1 | 23 | |
| TNF | 3 | 25% ± 5% | 1 | 14 | |
| P2RY8 | 4 | 20% ± 3% | 1 | 26 | |
| CD3D | 7 | 71% ± 28% | 2 | 34 | |
| CD2 | 7 | 62% ± 23% | 2 | 35 | |
| LIME1 | 5 | 38% ± 6% | 2 | 22 | |
| CD96 | 6 | 38% ± 15% | 2 | 33 | |
| CXCR3 | 4 | 33% ± 4% | 2 | 17 | |
| FAS | 3 | 18% ± 1% | 2 | 9 |
| GO_0001920 | Biological process | negative regulation of receptor recycling |
| GO_0023035 | Biological process | CD40 signaling pathway |
| Cell type name | effector CD4-positive, alpha-beta T cell |
| Synonyms | effector CD4-positive alpha-beta T lymphocyte effector CD4-positive alpha-beta T-cell effector CD4-positive alpha-beta T-lymphocyte |
| Description | A CD4-positive, alpha-beta T cell with the phenotype CCR7-negative, CD45RA-positive. |
| Parent | CL_0000624 |